Surprisingly, we have also found an increase in the expression of costimulatory receptor OX40 with DTT-COS1 treatment, and related receptor 4-1BB with DTT-COS12 treatment in TILs, which probably helped the infiltration of effect T cells and tumor resist in TME. The gene discussed is TNFRSF9; the disease is neoplasm.